Horizon Therapeutics PLC (NASDAQ:HZNP)
| 90.32 Delayed Data As of May 20 |  +0.98 / +1.10%Today’s Change | 82.51 Today|||52-Week Range 120.54 | -16.18% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | 39.5M | -166.8M | -410.5M | -74.2M | |
| Depreciation | 138.3M | 221.8M | 283.4M | 275.7M | ||
| Total Other Cash Flow | 195.7M | 244.2M | 393.6M | 201.7M | ||
| Funds From Operations | 193.0M | 233.7M | 134.2M | 338.7M | ||
| Funds From/For Other Operating Expenses | -4.1M | -135.8M | -146.0M | 144.2M | ||
| Net Cash Flow - Operating Activities | 197.2M | 369.5M | 280.2M | 194.5M | ||
| Investing | Increase In Investments | -71.8M | -3.9M | 0.00 | 0.00 | |
| Decrease In Investments | 107.4M | 0.00 | 0.00 | 0.00 | ||
| Capital Expenditures | -7.2M | -15.7M | -4.3M | -4.8M | ||
| Fixed Asset Disposal | -- | -- | 69.4M | 44.4M | ||
| Net Assets From Acquisitions | -1.0B | -1.4B | -167.2M | 0.00 | ||
| Other Investing - Uses | 0.00 | 0.00 | 0.00 | -12.0M | ||
| Net Cash Flow Investing | -993.9M | -1.4B | -102.2M | 27.7M | ||
| Financing | Short Term Borrowings | -3.0M | 0.00 | 0.00 | 0.00 | |
| Long Term Borrowings | 1.7B | 656.2M | 1.7B | 818.0M | ||
| Long Term Debt Reduction | -299.0M | -4.0M | -1.6B | -845.7M | ||
| Net Proceeds Stock Sale | 27.8M | 10.4M | 11.0M | 25.6M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | -992.0K | 0.00 | ||
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 3.0M | 5.5M | 26.5M | 14.5M | ||
| Net Cash Flow - Financing | 1.4B | 657.1M | 58.4M | -16.6M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -790.0K | -1.2M | 5.3M | -1.4M | |
| Net Change In Cash | 642.7M | -349.4M | 236.4M | 205.6M | ||
